It's coronavirus vaccine candidate, NVX-CoV2373, is in the late-phase of clinical development using a Novavax’ nanoparticle technology and includes its proprietary MatrixM™ adjuvant.
FDA fast tracks another possible COVID-19 vaccine
The Food and Drug Administration has given another possible COVID-19 vaccine fast track designation. The vaccine, produced by..
ABC Action News
